Clinical epidemiologists experienced in quantitative approaches to etiologic, prevention and treatment studies provide insights that span the translational continuum regardless of disease focus.
Addressing the complexities of the application of screening and treatment recommendations to individualized patients is the focus of the relatively new field of physician/patient decision-making.
The burgeoning genetic data newly available through methods such as genome-wide association studies and next-generation sequencing data demand the skills of specially-trained epidemiologists. The use of this genetic information with applications to risk assessment and pharmaco-genetics plays a major role in the future of personalized medicine. The DCS genetic epidemiologists provide the study design and analytical resources needed by TUSM investigators who are studying complex traits associated with risk of cancer and metabolic disorders.